Author:
Boyle P.,Roehrborn C.,Harkaway R.,Logie J.,de la Rosette J.,Emberton M.
Reference23 articles.
1. Benign prostatic hyperplasia: a progressive disease of aging men;Emberton;Urology,2003
2. Lepor H. Terazosin in the treatment of benign prostatic hyperplasia. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P, editors. Textbook of Benign Prostatic Hyperplasia. Oxford: ISIS Medical; 1996. p. 279–86.
3. The effect of finasteride in men with benign prostatic hyperplasia.;Gormley;N Engl. J. Med.,1992
4. Finasteride, an inhibitor of 5-alpha reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia;McConnell;J. Clin. Endocrinol. Metab.,1992
5. Efficacy and safety of a dual inhibitor of 5-alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia;Roehrborn;Urology,2002
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献